Search results
Earnings call: OMNIQ reports revenue growth and fintech expansion By Investing.com
Investing.com· 14 hours agoOMNIQ Corp (OTC:OMQS) has announced a positive start to the year in their First Quarter 2024...
Extruded Pharmaceuticals to make stock market debut after RTO deal with Amur
Proactive Investors· 4 days agoAmur Minerals Corporation (AIM:AMC, OTC:AMMCF) PLC's 18-year association with the AIM market will...
Earnings call: CV Sciences posts a revenue of $4 million
Investing.com· 3 days agoCV Sciences (OTC: CVSI ), a leader in the natural product retail channel, has reported a revenue of...
Earnings call: Nikon forecasts steady growth and sustainable focus
Investing.com· 5 days agoNikon (OTC: NINOY ) Corporation (TYO: 7731) has released its financial results for the past fiscal...
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
Benzinga· 3 days agoPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA ALBPS, ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics ...
Earnings call: SmartCentres REIT reports strong Q1 with rental growth By Investing.com
Investing.com· 4 days agoSmartCentres REIT (SRU.UN) has kicked off the year with solid financial and operational performance,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoSalt Lake City, May 15, 2024 (GLOBE NEWSWIRE) -- omniQ Corporation (OTC PINK: OMQS) ("omniQ" or "the Company"), a leading provider of Artificial Intelligence (AI)-based solutions ...
Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress By Investing.com
Investing.com· 3 days agoInnate Pharma SA (OTC:IPHYF) (IPHA) discussed its first quarter 2024 financial results and provided...
Udenyca: Side effects and what to do about them
Medical News Today· 7 days agoUdenyca is a prescription drug used to help prevent infection with chemotherapy. Learn about the serious side effects it can cause and how to manage...
BridgeBio's Acoramidis shows promise in heart disease study By Investing.com
Investing.com· 4 days agoThe study findings were presented at the European Society of Cardiology (ESC) Heart Failure Congress...